Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CSII Cardiovascular Systems	$20.00	$19.98	$12.26 ▼ $20.57	$843.96M	0.74	765,906 shs	4,300 shs
GKOS Glaukos	$103.68 -2.7%	$97.18	$77.10 ▼ $163.71	$5.93B	0.82	743,626 shs	660,520 shs
INSP Inspire Medical Systems	$130.48 -6.3%	$139.08	$123.00 ▼ $225.00	$3.84B	1.25	556,588 shs	584,412 shs
IRTC iRhythm Technologies	$135.94 +0.9%	$143.06	$55.92 ▼ $157.13	$4.34B	1.41	490,555 shs	562,298 shs
MMSI Merit Medical Systems	$93.49 -1.8%	$94.70	$82.62 ▼ $111.45	$5.53B	0.65	540,037 shs	448,468 shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CSII Cardiovascular Systems	0.00%	0.00%	0.00%	0.00%	0.00%
GKOS Glaukos	0.00%	+0.17%	+6.51%	+15.14%	-13.69%
INSP Inspire Medical Systems	0.00%	+1.63%	+1.21%	-11.30%	-0.79%
IRTC iRhythm Technologies	0.00%	-4.51%	-6.56%	+33.16%	+43.40%
MMSI Merit Medical Systems	0.00%	-0.07%	-0.09%	+1.58%	+7.23%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CSII Cardiovascular Systems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GKOS Glaukos	4.3435 of 5 stars	4.4	1.0	0.0	4.4	2.4	1.7	0.6
INSP Inspire Medical Systems	4.9079 of 5 stars	4.4	2.0	0.0	4.8	3.5	2.5	1.9
IRTC iRhythm Technologies	1.0351 of 5 stars	2.5	1.0	0.0	0.0	2.1	0.8	0.6
MMSI Merit Medical Systems	4.3195 of 5 stars	3.4	1.0	0.0	3.8	3.5	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CSII Cardiovascular Systems	0.00	N/A	N/A	N/A
GKOS Glaukos	2.75	Moderate Buy	$134.67	29.89% Upside
INSP Inspire Medical Systems	2.73	Moderate Buy	$211.91	62.41% Upside
IRTC iRhythm Technologies	2.90	Moderate Buy	$138.60	1.96% Upside
MMSI Merit Medical Systems	2.89	Moderate Buy	$109.11	16.71% Upside

Current Analyst Ratings Breakdown

Latest IRTC, GKOS, MMSI, INSP, and CSII Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/8/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$108.00
6/11/2025	IRTC iRhythm Technologies	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$130.00 ➝ $160.00
5/23/2025	MMSI Merit Medical Systems	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $110.00
5/22/2025	IRTC iRhythm Technologies	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$130.00 ➝ $167.00
5/21/2025	MMSI Merit Medical Systems	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$108.00 ➝ $112.00
5/21/2025	MMSI Merit Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$106.00 ➝ $108.00
5/15/2025	MMSI Merit Medical Systems	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$100.00 ➝ $108.00
5/6/2025	GKOS Glaukos	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$110.00 ➝ $72.00
5/6/2025	INSP Inspire Medical Systems	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$220.00 ➝ $200.00
5/6/2025	INSP Inspire Medical Systems	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$235.00 ➝ $195.00
5/6/2025	INSP Inspire Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$195.00 ➝ $174.00

(Data available from 7/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CSII Cardiovascular Systems	$239.84M	3.52	N/A	N/A	$6.12 per share	3.27
GKOS Glaukos	$383.48M	15.45	N/A	N/A	$13.91 per share	7.45
INSP Inspire Medical Systems	$802.80M	4.79	$1.71 per share	76.24	$23.01 per share	5.67
IRTC iRhythm Technologies	$618.59M	7.02	N/A	N/A	$2.90 per share	46.88
MMSI Merit Medical Systems	$1.36B	4.07	$5.61 per share	16.67	$23.67 per share	3.95

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CSII Cardiovascular Systems	-$36.93M	-$0.97	N/A	N/A	N/A	-15.79%	-15.39%	-11.93%	N/A
GKOS Glaukos	-$146.37M	-$2.37	N/A	N/A	N/A	-31.40%	-10.66%	-8.06%	7/30/2025 (Estimated)
INSP Inspire Medical Systems	$53.51M	$2.17	60.13	40.52	1.99	7.92%	10.00%	8.68%	8/5/2025 (Estimated)
IRTC iRhythm Technologies	-$113.29M	-$3.14	N/A	N/A	N/A	-15.90%	-101.04%	-9.55%	7/30/2025 (Estimated)
MMSI Merit Medical Systems	$120.36M	$2.04	45.83	24.93	3.02	8.81%	15.52%	8.72%	7/30/2025 (Estimated)

Latest IRTC, GKOS, MMSI, INSP, and CSII Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	IRTC iRhythm Technologies	-$0.53	N/A	N/A	N/A	N/A	N/A
8/5/2025	Q2 2025	INSP Inspire Medical Systems	$0.22	N/A	N/A	N/A	$214.50 million	N/A
7/30/2025	Q2 2025	GKOS Glaukos	-$0.26	N/A	N/A	N/A	$115.49 million	N/A
7/30/2025	Q2 2025	MMSI Merit Medical Systems	$0.8480	N/A	N/A	N/A	$372.47 million	N/A
5/5/2025	Q1 2025	INSP Inspire Medical Systems	-$0.23	$0.10	+$0.33	$0.10	$194.89 million	$201.32 million
5/1/2025	Q1 2025	IRTC iRhythm Technologies	-$0.89	-$0.95	-$0.06	-$0.97	$153.39 million	$158.68 million
4/30/2025	Q1 2025	GKOS Glaukos	-$0.33	-$0.22	+$0.11	-$0.32	$102.78 million	$106.66 million
4/24/2025	Q1 2025	MMSI Merit Medical Systems	$0.75	$0.86	+$0.11	$0.49	$352.57 million	$355.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CSII Cardiovascular Systems	N/A	N/A	N/A	N/A	N/A
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
MMSI Merit Medical Systems	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CSII Cardiovascular Systems	0.08	6.04	4.92
GKOS Glaukos	0.09	6.49	5.62
INSP Inspire Medical Systems	N/A	9.01	7.44
IRTC iRhythm Technologies	7.47	5.71	5.58
MMSI Merit Medical Systems	0.51	4.87	3.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CSII Cardiovascular Systems	86.61%
GKOS Glaukos	99.04%
INSP Inspire Medical Systems	94.91%
IRTC iRhythm Technologies	N/A
MMSI Merit Medical Systems	99.66%

Insider Ownership

Company	Insider Ownership
CSII Cardiovascular Systems	3.80%
GKOS Glaukos	5.80%
INSP Inspire Medical Systems	4.10%
IRTC iRhythm Technologies	1.10%
MMSI Merit Medical Systems	3.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CSII Cardiovascular Systems	780	42.20 million	40.59 million	Optionable
GKOS Glaukos	780	57.14 million	53.83 million	Optionable
INSP Inspire Medical Systems	1,246	29.49 million	28.29 million	Optionable
IRTC iRhythm Technologies	2,000	31.93 million	31.57 million	Optionable
MMSI Merit Medical Systems	7,400	59.10 million	57.21 million	Optionable

IRTC, GKOS, MMSI, INSP, and CSII Headlines

Recent News About These Companies

Emerald Mutual Fund Advisers Trust Decreases Stock Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 12 at 8:44 AM | marketbeat.com

Teacher Retirement System of Texas Decreases Stock Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 11 at 4:00 AM | marketbeat.com

Why Merit Medical Systems (MMSI) Stock Is Trading Up Today

July 8, 2025 | msn.com

Merit Medical is getting a new CEO

July 8, 2025 | massdevice.com

Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook

July 8, 2025 | benzinga.com

5MMSI : What 14 Analyst Ratings Have To Say About Merit Medical Systems

July 8, 2025 | benzinga.com

Needham & Company LLC Reiterates Buy Rating for Merit Medical Systems (NASDAQ:MMSI)

July 8, 2025 | marketbeat.com

Strategic Leadership Transition and Strong Financial Performance Justify Buy Rating for Merit Medical Systems

July 8, 2025 | tipranks.com

Hold Rating Maintained for Merit Medical Systems Amid Leadership Change and Cautious Market Outlook

July 8, 2025 | tipranks.com

Buy Rating for Merit Medical Systems Driven by New CEO Appointment and Strong Revenue Guidance

July 8, 2025 | tipranks.com

Principal Financial Group Inc. Has $33.82 Million Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 8, 2025 | marketbeat.com

Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday

July 8, 2025 | benzinga.com

Merit Medical Names Martha Aronson as New President and Chief Executive Officer

July 7, 2025 | globenewswire.com

Analysts Set Merit Medical Systems, Inc. (NASDAQ:MMSI) PT at $109.11

July 7, 2025 | americanbankingnews.com

Impax Asset Management Group plc Lowers Stock Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 6, 2025 | marketbeat.com

Allspring Global Investments Holdings LLC Increases Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

July 5, 2025 | marketbeat.com

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Recommendation of "Moderate Buy" by Brokerages

July 4, 2025 | marketbeat.com

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025

July 3, 2025 | gurufocus.com

Merit Medical Systems Inc (MMSI) Announces Upcoming Financial Results Release and Investor Call ...

July 3, 2025 | gurufocus.com

Merit Medical Systems, Inc. to Release Q2 2025 Financial Results and Host Investor Conference Call on July 30

July 3, 2025 | quiverquant.comQ

Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025 | MMSI Stock News

July 3, 2025 | gurufocus.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
330% Returns YTD: Is CoreWeave's Momentum Softening?
By Nathan Reiff | June 18, 2025
View 330% Returns YTD: Is CoreWeave's Momentum Softening?

IRTC, GKOS, MMSI, INSP, and CSII Company Descriptions

Cardiovascular Systems NASDAQ:CSII

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

Glaukos NYSE:GKOS

$103.68 -2.87 (-2.69%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$103.81 +0.13 (+0.12%)

As of 07/11/2025 05:48 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Inspire Medical Systems NYSE:INSP

$130.48 -8.77 (-6.30%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$130.32 -0.16 (-0.12%)

As of 07/11/2025 07:54 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

iRhythm Technologies NASDAQ:IRTC

$135.94 +1.23 (+0.91%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$135.56 -0.38 (-0.28%)

As of 07/11/2025 04:20 PM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Merit Medical Systems NASDAQ:MMSI

$93.49 -1.68 (-1.77%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$93.46 -0.02 (-0.03%)

As of 07/11/2025 04:31 PM Eastern

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time